Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Experts dismiss Parkinson's research

  • Comment
Research showing aspirin and non-steroidal anti-inflammatory drugs (NSAIDS) may have a protective effect against Parkinson’s Disease has been dismissed by experts.
Findings in a study of 293 recently-diagnosed Parkinson’s patients showed patients who took aspirin more than twice a week for at least a month 20% less likely to develop the disease.

Regular users of NSAIDS such as ibuprofen were half as likely to develop the disease. For those who had used NSAIDS for more than two years, the risk of developing the disease dropped to 44%.

But the Parkinson’s Disease Society has dismissed the findings. Dr Kieran Breen, the society's director of research and development, said: ‘The research study does not establish that over the counter medications such as aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) prevent Parkinson’s. Rather, it suggests that inflammation may play some kind of role in Parkinson’s.

'The research was not designed to establish a causal link between the use of over the counter medication and Parkinson’s.

'Other research studies, using greater numbers of people, have investigated the potential association of taking non-steroidal anti-inflammatory drugs and the risk of developing Parkinson’s, but could not find a link.'

Neurology (2007) 69:1836-1842
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.